Navigation Links
Trial Lawyer TV Ads for Medical Malpractice Lawsuits Grew 1,400 Percent in Last Four Years, Study Shows
Date:9/8/2009

WASHINGTON, Sept. 8 /PRNewswire-USNewswire/ -- Television advertisements soliciting plaintiffs for medical malpractice lawsuits increased from about 10,150 ads in 2004 to more than 156,000 ads in 2008--nearly a 1,400 percent increase in four years, according to a new study released today. The study showed that spending for these ads increased from $3.8 million to nearly $62 million during this time period--a 1,300 percent increase in 2008-adjusted dollars.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080919/USCHAMBERLOGO)

Lisa A. Rickard, president of the U.S. Chamber Institute for Legal Reform, which sponsored the study, said the finding is a window into what appears to be the growing role of medical malpractice cases in the overall litigation landscape. "Lawsuits are ultimately a business driven by the plaintiffs' bar, and when you see the marketing of medical malpractice lawsuits exploding like this, it tells you that these lawsuits are a growing sector within the larger lawsuit industry," she said.

The study was conducted by the Campaign Media Analysis Group. Evan Tracey, the firm's president and veteran advertising analyst, said, "There is no question that the number of ads airing has increased dramatically," said Tracey. "As with every other advertising sector, marketers tend to go with what is working," he said.

This new evidence of growth in plaintiffs' lawyer medical malpractice lawsuits comes amid an increased focus on medical liability reform--or lack thereof--in the larger healthcare reform debate.

In August, former Vermont Governor and Democratic National Committee Chairman Dr. Howard Dean made a telling statement when he answered a question at a Congressional town hall meeting about the lack of medical liability reform in the current healthcare reform proposals. Dean responded, "The reason that tort reform is not in the bill is because the people that wrote it did not want to take on the trial lawyers in addition to everybody else they were taking on, and that is the plain and simple truth."

"This study is yet another piece of evidence that we need meaningful medical liability reform as a key ingredient of any workable healthcare reform package," said Rickard.

To see the findings of the plaintiffs' lawyer medical malpractice advertising study, along with the methodology, go to www.instituteforlegalreform.com/medmalstudy.

ILR seeks to promote civil justice reform through legislative, political, judicial, and educational activities at the national, state, and local levels.

The U.S. Chamber is the world's largest business federation representing more than 3 million businesses and organizations of every size, sector, and region.

www.uschamber.com www.chamberpost.com


'/>"/>
SOURCE U.S. Chamber Institute for Legal Reform
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Hard To Treat Diseases (HTDS) Completes Injection Clinical Trial
2. ERT Achieves Cardiac Safety Milestone after Completing 150th TET Trial
3. China Sky One Medical, Inc. Submits Application to Perform Clinical Trials for Two New Eye Drugs to SFDA
4. Bionovo to Present Positive Results from Phase 2 Trial of Menerba for Vasomotor Symptoms to the International Community
5. NIAID funds clinical trials that address the problem of antimicrobial resistance
6. Key Stakeholders to Discuss Regulatory Issues Related to the Use of Study Endpoints in Multinational Clinical Trials
7. September 2009 is Atrial Fibrillation Month
8. Video: RE-LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non-valvular Atrial Fibrillation Patients
9. Video: Phase III Head to Head Trial Showed Ticagrelor Reduced Cardiovascular Death and Heart Attacks Over Clopidogrel in Acute Coronary Syndromes Patients
10. Cardiome Announces Upcoming Presentation Of Results Of Phase 2b Clinical Trial Of Vernakalant (Oral) At The European Society Of Cardiology Congress 2009
11. CenterWatch Celebrates 15-Year Milestone as Leading Information Provider for the Clinical Trials Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/24/2017)... ... ... Millions of families and businesses worldwide depend on high quality water from ... water. However, well water can also become contaminated with bacteria and odors from flood ... The EPA does not regulate private drinking water wells. Many states and towns do ...
(Date:9/24/2017)... ... ... boy was walking home and feeling down about himself. He didn’t think he was good ... he can do whatever he wants to do if he puts his mind to it. ... God created him with special talents and gifts. We see his internal dialogue change. He ...
(Date:9/24/2017)... ... ... The Other Sheep”: the ceremonial laws of Moses and the Holy Law of God reexamined. ... author, Maurice Caines. Maurice Caines resides in the sunny isle of Florida, but he ... Adventist Church for many years. He was previously a member of the Anglican Church ...
(Date:9/23/2017)... San Francisco, CA (PRWEB) , ... September 23, 2017 , ... ... Bay Area, is proud to announce a new blog post focused on the ARTAS® ... loss, they understandably hope to turn to the latest, most technologically sophisticated methods of ...
(Date:9/22/2017)... Albert Lea, MN (PRWEB) , ... September 22, 2017 , ... ... and video) at its rally to interview citizens on why they are rallying against ... stories and commitment to this effort against Dr. Noseworthy’s (CEO) decision to close the ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... 2017  Eli Lilly and Company (NYSE: ... data for lasmiditan, an investigational, oral, first-in-class molecule for ... improvements compared to placebo in the Phase 3 SPARTAN ... 18th Congress of the International Headache Society (IHC) in ... presented today demonstrate lasmiditan,s potential to reduce pain and ...
(Date:9/7/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... will be participating in the Morgan Stanley 15 th ... hotel in New York.  Zimmer Biomet will present on ... A live webcast of the presentation can ... http://investor.zimmerbiomet.com .   ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
Breaking Medicine Technology: